Free Trial

Allakos (ALLK) Insider Trading & Ownership

Allakos logo
$0.94 -0.07 (-6.94%)
(As of 11/20/2024 ET)

Allakos (NASDAQ:ALLK) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.12%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$87,934.64
Get ALLK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Allakos stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ALLK Insider Buying and Selling by Quarter

Allakos Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/28/2024Harlan Baird RadfordCFOSell87,064$1.01$87,934.64  
(Data available from 1/1/2013 forward)

ALLK Insider Trading Activity - Frequently Asked Questions

The list of insiders at Allakos includes Harlan Baird Radford, and Paul Edward Walker. Learn more on insiders at ALLK.

16.12% of Allakos stock is owned by insiders. Learn more on ALLK's insider holdings.

The following insider sold ALLK shares in the last 24 months: Harlan Baird Radford ($87,934.64).

Insiders have sold a total of 87,064 Allakos shares in the last 24 months for a total of $87,934.64 sold.

Allakos Key Executives

  • Dr. Robert Alexander Ph.D. (Age 54)
    CEO & Director
    Compensation: $1.5M
  • Dr. Adam L. Tomasi Ph.D. (Age 54)
    President
    Compensation: $1.15M
  • Mr. Baird Radford III (Age 54)
    Chief Financial Officer
    Compensation: $731.35k
  • Ms. Mary Cromwell Ph.D.
    Chief Technical Officer
  • Dr. Chin Lee M.D. (Age 54)
    M.P.H., Chief Medical Officer
  • Mr. Alan Chang
    Director of Medical Affairs & Data Analytics


This page (NASDAQ:ALLK) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners